The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Medical - Distribution industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.
70 of 153
P/E 24.4 vs period average 21.3 Richer than its history
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/6 | ![]() | $41.86 | 50.2 | 0 | 76 | 94 | 100 |
| 2/6 | ![]() | $232.51 | 35.3 | 12 | 88 | 76 | 94 |
| 3/6 | ![]() | $85.71 | 24.7 | 41 | 12 | 71 | 88 |
| 4/6 | ![]() | $889.50 | 22.5 | 53 | 94 | 65 | 76 |
| 5/6 | ![]() | $51.72 | 12.9 | 76 | 41 | 88 | 53 |
| 6/6 | ![]() | $319.58 | 24.4 | 29 | 35 | 41 | 35 |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Upgrades and downgrades on the sector's stocks
Insider purchases in the sector's stocks
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $9B | 0.44% |
| XLVState Street Health Care Select Sector SPDR ETF | 100.0% | $43B | 0.08% |
| VHTVanguard Health Care ETF | 100.0% |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
| $20B |
| 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $3B | 0.38% |
The percentage is the sector's share of the fund's assets, per the latest available data.